SAN DIEGO — ViaCyte, Inc., a privately-held regenerative medicine company with the first pluripotent stem cell-derived islet replacement therapy for the treatment of diabetes in clinical-stage development, today announced that the Company has entered into a non-exclusive licensing agreement with Takara Bio, Inc. Takara will utilize certain portions of ViaCyte’s cell differentiation technology to expand […]

Stockholm – IFS, the global enterprise applications company, announces that Sartorius AG — a leading pharmaceutical and laboratory equipment supplier—will implement IFS Field Service Management™ at 50 sites worldwide. The software is a core part of the Enterprise Service Management offering. The agreement includes licenses and services worth more than 1.5 million euros. Following a […]

WARREN, N.J. — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today the appointment of Lars Boesgaard as Vice President and Chief Financial Officer. Mr. Boesgaard, who joined Roka in 2009 and currently serves as Vice President, Finance and Controller, succeeds […]

SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of its 3D BiologyTM portfolio with the commercial launch of the nCounter® PanCancer Profiles, seven new gene expression panels each designed to interrogate a focused area of cancer biology including immuno-oncology. The […]

SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced a formal agreement with Thermo Fisher Scientific to exchange instrument controls to improve the productivity and user experience of customers using software and instruments from both companies. Under the new agreement, Agilent and Thermo Fisher are exchanging instrument-control driver documentation and software for liquid […]

SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that the Australian Genome Research Facility Ltd—a nonprofit organization dedicated to enabling world-class genomics research throughout Australia—is now an Agilent Certified Service Provider for next-generation sequencing. Agilent certifies select laboratories that leverage the company’s market-leading technologies to provide analysis services of the highest quality. […]

Lexington, Mass. –— Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the launch of Simoa 2.0, its next-generation ultrasensitive immunoassay platform. Simoa 2.0 addresses many customer requests and input collected during the rapid growth of Simoa’s first year and a half on […]

FREMONT, Calif. — WaferGen Bio-systems, Inc. (NASDAQ:WGBS) today announced that the U.S. Patent and Trademark Office (USPTO) has granted U.S. Patent 9,132,427 and has issued a Notice of Allowance for U.S. Patent Application 12/624,399 with both method and system claims utilizing multi-well chips, respectively. With the grant and allowance of these applications, WaferGen now owns […]

SAN DIEGO, Calif. — Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY® Dx PLUS assays for gene-specific mutation testing to aid in the selection of targeted therapy regimens. Agena Bioscience will introduce the first diagnostic kits in partnership with Diatech Pharmacogenetics. The MassARRAY Dx PLUS assays improve upon existing methods […]

SAN DIEGO, Calif. — Agena Bioscience™ today announced expanded use of its MassARRAY® System for High Throughput Molecular Blood Group Genotyping. “Large scale genotyping provides a reliable, cost-effective method for comprehensive donor antigen typing in immunohematology laboratories. The MassARRAY System provides an open platform for assay development, enabling blood centers to develop and validate tests […]